Literature DB >> 3352511

Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome.

N E Anderson1, C Budde-Steffen, M K Rosenblum, F Graus, D Ford, B J Synek, J B Posner.   

Abstract

The clinical and pathological findings in 4 adults with cancer and opsoclonus were compared with those of 15 other patients described elsewhere. The clinical syndrome of paraneoplastic opsoclonus is characterized by the acute onset of opsoclonus and truncal ataxia, often accompanied by encephalopathy, myoclonus and a cerebrospinal fluid pleocytosis. Unlike most other paraneoplastic syndromes, the course is often remitting and relapsing. Neuropathological examination in 3 of our patients showed lymphocytic cuffing of occasional blood vessels throughout the central nervous system, associated with a mild, diffuse proliferation of microglia in 1 patient. Apart from a mild, patchy loss of Purkinje cells in 1 patient, there was no loss of neurons from the cerebellum, brainstem, cerebral hemispheres, or spinal cord. These patients differ from those with the more common paraneoplastic cerebellar degeneration by the predominance of truncal over limb ataxia, the presence of myoclonus, the absence of severe dysarthria, a tendency for remission, and the preservation of Purkinje cells.

Entities:  

Mesh:

Year:  1988        PMID: 3352511     DOI: 10.1097/00005792-198803000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  18 in total

1.  Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.

Authors:  J R Berger; E Mehari
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 3.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

4.  Paraneoplastic Diseases of the Nervous System.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-11       Impact factor: 3.598

5.  Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

Authors:  J E Greenlee; H R Brashear; K A Jaeckle; A Geleris; K Jordan
Journal:  West J Med       Date:  1992-02

6.  Opsoclonus-myoclonus syndrome in an adult with malignant melanoma.

Authors:  K-Y Jung; J Youn; C-S Chung
Journal:  J Neurol       Date:  2006-05-24       Impact factor: 4.849

Review 7.  Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature.

Authors:  Alberto Vogrig; Andrea Bernardini; Gian Luigi Gigli; Elisa Corazza; Alessandro Marini; Samantha Segatti; Martina Fabris; Jérôme Honnorat; Mariarosaria Valente
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

8.  Opsoclonus-myoclonus as a manifestation of Lyme disease.

Authors:  L Peter; J Jung; C Tilikete; P Ryvlin; F Mauguiere
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

9.  Neurological sequelae of the dancing eye syndrome.

Authors:  K R Pohl; J Pritchard; J Wilson
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

10.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.